List Name |
Annotation |
Enrichment |
p-value |
protein ubiquitination |
AmiGO Browser |
8.43 |
1.38e-03 |
ribonucleoside metabolic process |
AmiGO Browser |
33.71 |
1.56e-03 |
protein modification by small protein conjugation |
AmiGO Browser |
7.49 |
2.13e-03 |
positive regulation of cellular biosynthetic process |
AmiGO Browser |
8.09 |
6.26e-03 |
positive regulation of biosynthetic process |
AmiGO Browser |
6.60 |
0.01 |
nucleoside metabolic process |
AmiGO Browser |
12.64 |
0.01 |
heart looping |
AmiGO Browser |
28.90 |
0.03 |
heart morphogenesis |
AmiGO Browser |
28.90 |
0.03 |
positive regulation of interleukin-12 biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
ceramide biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
metabolic compound salvage |
AmiGO Browser |
25.28 |
0.04 |
pyrimidine nucleoside metabolic process |
AmiGO Browser |
25.28 |
0.04 |
positive regulation of carbohydrate metabolic process |
AmiGO Browser |
22.47 |
0.04 |
regulation of lipid biosynthetic process |
AmiGO Browser |
22.47 |
0.04 |
activation of MAPK activity |
AmiGO Browser |
5.95 |
0.04 |
positive regulation of protein biosynthetic process |
AmiGO Browser |
5.86 |
0.05 |
imprinting |
AmiGO Browser |
20.23 |
0.05 |
regulation of carbohydrate metabolic process |
AmiGO Browser |
20.23 |
0.05 |
sphingoid biosynthetic process |
AmiGO Browser |
20.23 |
0.05 |
purine ribonucleoside metabolic process |
AmiGO Browser |
20.23 |
0.05 |
purine nucleoside metabolic process |
AmiGO Browser |
20.23 |
0.05 |
regulation of exit from mitosis |
AmiGO Browser |
20.23 |
0.05 |
positive regulation of lipid metabolic process |
AmiGO Browser |
18.39 |
0.05 |
regulation of steroid metabolic process |
AmiGO Browser |
16.86 |
0.06 |
regulation of fatty acid metabolic process |
AmiGO Browser |
16.86 |
0.06 |
positive regulation of MAPK activity |
AmiGO Browser |
5.12 |
0.06 |
regulation of interleukin-12 biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
interleukin-12 biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
transcription from RNA polymerase II promoter |
AmiGO Browser |
1.83 |
0.06 |
glycolipid biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
DNA fragmentation during apoptosis |
AmiGO Browser |
13.48 |
0.07 |
G1 DNA damage checkpoint |
AmiGO Browser |
12.64 |
0.08 |
G2 phase of mitotic cell cycle |
AmiGO Browser |
12.64 |
0.08 |
G2 phase |
AmiGO Browser |
12.64 |
0.08 |
DNA alkylation |
AmiGO Browser |
11.24 |
0.09 |
interleukin-12 production |
AmiGO Browser |
11.24 |
0.09 |
DNA methylation |
AmiGO Browser |
11.24 |
0.09 |
regulation of translation |
AmiGO Browser |
2.88 |
0.09 |
neutral amino acid transport |
AmiGO Browser |
10.65 |
0.09 |
positive regulation of anti-apoptosis |
AmiGO Browser |
10.11 |
0.09 |
positive regulation of protein metabolic process |
AmiGO Browser |
3.82 |
0.10 |
myofibril assembly |
AmiGO Browser |
9.63 |
0.10 |
muscle cell development |
AmiGO Browser |
9.63 |
0.10 |
striated muscle cell development |
AmiGO Browser |
9.63 |
0.10 |
sphingolipid biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
phospholipid transport |
AmiGO Browser |
9.63 |
0.10 |
regulation of cellular biosynthetic process |
AmiGO Browser |
2.70 |
0.10 |
cell structure disassembly during apoptosis |
AmiGO Browser |
9.19 |
0.10 |
apoptotic nuclear changes |
AmiGO Browser |
9.19 |
0.10 |
nucleotide catabolic process |
AmiGO Browser |
9.19 |
0.10 |